OBJECTIVE Endoscopic third ventriculostomy (ETV) is now established as a viable treatment option for a subgroup of children with hydrocephalus. Here, the authors report prospective, multicenter results from the Hydrocephalus Clinical Research Network (HCRN) to provide the most accurate determination of morbidity, complication incidence, and efficacy of ETV in children and to determine if intraoperative predictors of ETV success add substantially to preoperative predictors. METHODS All children undergoing a first ETV (without choroid plexus cauterization) at 1 of 7 HCRN centers up to June 2013 were included in the study and followed up for a minimum of 18 months. Data, including detailed intraoperative data, were prospectively collected as part of the HCRN's Core Data Project and included details of patient characteristics, ETV failure (need for repeat hydrocephalus surgery), and, in a subset of patients, postoperative complications up to the time of discharge. RESULTS Three hundred thirty-six eligible children underwent initial ETV, 18.8

作者：Abhaya V, Kulkarni；Jay, Riva-Cambrin；Richard, Holubkov；Samuel R, Browd；D Douglas, Cochrane；James M, Drake；David D, Limbrick；Curtis J, Rozzelle；Tamara D, Simon；Mandeep S, Tamber；John C, Wellons；William E, Whitehead；John R W, Kestle

来源：Journal of neurosurgery. Pediatrics 2016 年 18卷 4期